{{Rsnum
|rsid=10244051
|Chromosome=7
|position=15024208
|Orientation=plus
|GMAF=0.4472
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 30.1 | 43.4 | 26.5
| HCB | 43.8 | 45.3 | 10.9
| JPT | 46.0 | 44.2 | 9.7
| YRI | 27.9 | 50.3 | 21.8
| ASW | 15.8 | 70.2 | 14.0
| CHB | 43.8 | 45.3 | 10.9
| CHD | 45.9 | 44.0 | 10.1
| GIH | 37.6 | 43.6 | 18.8
| LWK | 27.3 | 53.6 | 19.1
| MEX | 20.7 | 48.3 | 31.0
| MKK | 23.7 | 53.2 | 23.1
| TSI | 28.4 | 51.0 | 20.6
| HapMapRevision=28
}}
{{PMID Auto GWAS
|PMID=19060910
|Trait=Other metabolic traits
|Title=Genome-wide association analysis of metabolic traits in a birth cohort from a founder population
|RiskAllele=C
|Pval=1E-7
|OR=0.05
|ORtxt=[0.03-0.06] mmol/l increase
|OA=1
}}

{{PharmGKB
|RSID=rs10244051
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19060910; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. (Initial Sample Size: 4,763 individuals; Replication Sample Size: NR); (Region: 7p21.2; Reported Gene(s): Intergenic; Risk Allele: rs10244051-C); (p-value= 0.0000001).This variant is associated with Other metabolic traits.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740286
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs10244051
|overall_frequency_n=75
|overall_frequency_d=126
|overall_frequency=0.595238
|n_genomes=45
|n_genomes_annotated=0
|n_haplomes=64
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}